{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:21:29Z","timestamp":1788009689746,"version":"build-2784847793"},"reference-count":152,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jpha.2023.12.007","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T13:51:48Z","timestamp":1702129908000},"page":"100917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6938-4266","authenticated-orcid":false,"given":"Jiani","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2865-5303","authenticated-orcid":false,"given":"Hang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4535-3339","authenticated-orcid":false,"given":"Yichao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2023.12.007_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jpha.2023.12.007_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-022-00347-9","article-title":"Atrial fibrillation","volume":"8","author":"Brundel","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jpha.2023.12.007_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCRESAHA.120.316363","article-title":"Molecular basis of atrial fibrillation pathophysiology and therapy: A translational perspective","volume":"127","author":"Nattel","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s42000-018-0038-0","article-title":"Clinical pharmacology of glucagon-like peptide-1 receptor agonists","volume":"17","author":"Sfairopoulos","year":"2018","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.jpha.2023.12.007_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev-med-043021-014919","article-title":"New frontiers in obesity treatment: GLP-1 and nascent nutrient-stimulated hormone-based therapeutics","volume":"74","author":"Jastreboff","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108737","article-title":"GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis","volume":"174","author":"Karagiannis","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jpha.2023.12.007_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/dom.14066","article-title":"Number needed to treat in cardiovascular outcome trials of glucagon-like peptide-1 receptor agonists: A systematic review with temporal analysis","volume":"22","author":"Davies","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib8","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.7150\/ijbs.59965","article-title":"GLP-1 receptor agonists (GLP-1RAs): Cardiovascular actions and therapeutic potential","volume":"17","author":"Ma","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib9","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1172\/JCI114616","article-title":"Effects of acute hyperglycemia on myocardial glycolytic activity in humans","volume":"85","author":"Wisneski","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpha.2023.12.007_bib10","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jcmg.2019.08.030","article-title":"Myocardial efficiency: A fundamental physiological concept on the verge of clinical impact","volume":"13","author":"S\u00f6rensen","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.jpha.2023.12.007_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.789267","article-title":"Mitochondrial metabolism in myocardial remodeling and mechanical unloading: Implications for ischemic heart disease","volume":"8","author":"Jiang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2023.12.007_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cardfail.2020.04.005","article-title":"Myocardial ketones metabolism in heart failure","volume":"26","author":"Karwi","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.jpha.2023.12.007_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/CIRCRESAHA.116.310078","article-title":"Evolving concepts of myocardial energy metabolism: More than just fats and carbohydrates","volume":"119","author":"Lopaschuk","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11306-019-1557-7","article-title":"Comprehensive metabolomic and proteomic analyses reveal candidate biomarkers and related metabolic networks in atrial fibrillation","volume":"15","author":"Zhou","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpha.2023.12.007_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-015-0497-2","article-title":"Arrhythmia causes lipid accumulation and reduced glucose uptake","volume":"110","author":"Lenski","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224713","article-title":"Correlation between increased atrial expression of genes related to fatty acid metabolism and autophagy in patients with chronic atrial fibrillation","volume":"15","author":"Shingu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2023.12.007_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2019.05.112","article-title":"Remodeling of myocardial energy and metabolic homeostasis in a sheep model of persistent atrial fibrillation","volume":"517","author":"Jie","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2023.12.007_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.821754","article-title":"The four key genes participated in and maintained atrial fibrillation process via reprogramming lipid metabolism in AF patients","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.jpha.2023.12.007_bib20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/bph.13438","article-title":"Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-\u03b1\/sirtuin 1\/PGC-1\u03b1 pathway","volume":"173","author":"Liu","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2023.12.007_bib21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvaa143","article-title":"Ketones can become the major fuel source for the heart but do not increase cardiac efficiency","volume":"117","author":"Ho","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib22","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2174\/1381612824666180903125300","article-title":"Mitochondria and the pathophysiological mechanism of atrial fibrillation","volume":"24","author":"Li","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpha.2023.12.007_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101202","article-title":"Mitochondrial dysfunction underlies cardiomyocyte remodeling in experimental and clinical atrial fibrillation","volume":"8","author":"Wiersma","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2023.12.007_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-020-00827-7","article-title":"Cellular and mitochondrial mechanisms of atrial fibrillation","volume":"115","author":"Mason","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/CIRCULATIONAHA.111.029223","article-title":"Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: Implications for the antiarrhythmic effect of statins","volume":"124","author":"Reilly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jpha.2023.12.007_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063249","article-title":"Role of the ROS-JNK signaling pathway in hypoxia-induced atrial fibrotic responses in HL-1 cardiomyocytes","volume":"22","author":"Tsai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101432","article-title":"Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation","volume":"30","author":"Yang","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.jpha.2023.12.007_bib28","article-title":"Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.jpha.2023.12.007_bib29","article-title":"Enhancing fatty acids oxidation via l-carnitine attenuates obesity-related atrial fibrillation and structural remodeling by activating AMPK signaling and alleviating cardiac lipotoxicity","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2023.12.007_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13690","article-title":"Ceramide modulates electrophysiological characteristics and oxidative stress of pulmonary vein cardiomyocytes","volume":"52","author":"Huang","year":"2022","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jpha.2023.12.007_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-021-01431-2","article-title":"Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride","volume":"20","author":"Jendle","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.jpha.2023.12.007_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.14740\/cr1073","article-title":"Upstream therapy for atrial fibrillation prevention: The role of sacubitril\/valsartan","volume":"11","author":"De Vecchis","year":"2020","journal-title":"Cardiol. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/clc.23487","article-title":"Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial","volume":"43","author":"Zhao","year":"2020","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jjcc.2021.08.012","article-title":"Dietary \u03c9-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation","volume":"79","author":"Tu","year":"2022","journal-title":"J. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105803","article-title":"Regulator of G-protein signaling-4 attenuates cardiac adverse remodeling and neuronal norepinephrine release-promoting free fatty acid receptor FFAR3 signaling","volume":"23","author":"Carbone","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154333","article-title":"Serum and adipose dipeptidyl peptidase 4 in cardiovascular surgery patients: Influence of dipeptidyl peptidase 4 inhibitors","volume":"11","author":"Shibasaki","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117759","article-title":"Metformin therapy confers cardioprotection against the remodeling of gap junction in tachycardia-induced atrial fibrillation dog model","volume":"254","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031678","article-title":"SGLT2 inhibitors and their antiarrhythmic properties","volume":"23","author":"Kolesnik","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.017483","article-title":"Canagliflozin suppresses atrial remodeling in a canine atrial fibrillation model","volume":"10","author":"Nishinarita","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jpha.2023.12.007_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147371","article-title":"Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress","volume":"6","author":"Avula","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpha.2023.12.007_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00912","article-title":"Sodium-glucose cotransporter 2 inhibitors potentially prevent atrial fibrillation by ameliorating ion handling and mitochondrial dysfunction","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9040341","article-title":"Coenzyme Q10: Clinical applications in cardiovascular diseases","volume":"9","author":"Martelli","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.jpha.2023.12.007_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2468031","article-title":"Wenxin Keli regulates mitochondrial oxidative stress and homeostasis and improves atrial remodeling in diabetic rats","volume":"2020","author":"Gong","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpha.2023.12.007_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168463","article-title":"The role of mitochondrial dysfunction in atrial fibrillation: Translation to druggable target and biomarker discovery","volume":"22","author":"Pool","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trsl.2021.08.003","article-title":"Aldosterone suppresses cardiac mitochondria","volume":"239","author":"Hung","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cvr\/cvw007","article-title":"Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation","volume":"109","author":"Opacic","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib47","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1042\/CS20190578","article-title":"Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis","volume":"133","author":"Anthony","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.jpha.2023.12.007_bib48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib49","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.hrthm.2018.06.025","article-title":"Association of fibrotic remodeling and cytokines\/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation","volume":"15","author":"Abe","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jpha.2023.12.007_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/454427a","article-title":"Inflammation","volume":"454","author":"Weiss","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2023.12.007_bib51","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/eurheartj\/ehz953","article-title":"Infection and atrial fibrillation: Inflammation begets AF","volume":"41","author":"Boos","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jpha.2023.12.007_bib52","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/CIRCRESAHA.120.316710","article-title":"Atrial myocyte NLRP3\/CaMKII nexus forms a substrate for postoperative atrial fibrillation","volume":"127","author":"Heijman","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib53","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/07853890.2015.1042030","article-title":"Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?","volume":"47","author":"Ren","year":"2015","journal-title":"Ann. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117328","article-title":"Osteopontin induces atrial fibrosis by activating Akt\/GSK-3\u03b2\/\u03b2-catenin pathway and suppressing autophagy","volume":"245","author":"Lin","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.893729","article-title":"Epicardial adipose tissue-derived IL-1\u03b2 triggers postoperative atrial fibrillation","volume":"10","author":"Cabaro","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jpha.2023.12.007_bib56","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2010.09.068","article-title":"Periatrial epicardial fat, local pro- and anti-inflammatory balance, and atrial fibrillation","volume":"57","author":"Liu","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133052","article-title":"Free fatty acid effects on the atrial myocardium: Membrane ionic currents are remodeled by the disruption of T-tubular architecture","volume":"10","author":"O\u2019Connell","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2023.12.007_bib58","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1016\/j.jtcvs.2022.03.013","article-title":"Impact of proinflammatory epicardial adipose tissue and differentially enhanced autonomic remodeling on human atrial fibrillation","volume":"165","author":"Zhao","year":"2023","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jpha.2023.12.007_bib59","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1073\/pnas.93.20.11047","article-title":"Molecular identity and cellular distribution of advanced glycation endproduct receptors: Relationship of p60 to OST-48 and p90 to 80K-H membrane proteins","volume":"93","author":"Li","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2023.12.007_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017752","article-title":"Collagen cross-linking is associated with cardiac remodeling in hypertrophic obstructive cardiomyopathy","volume":"10","author":"Bi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jpha.2023.12.007_bib61","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1124\/jpet.118.252080","article-title":"Inhibition of advanced glycation end products formation attenuates cardiac electrical and mechanical remodeling and vulnerability to tachyarrhythmias in diabetic rats","volume":"368","author":"Chang","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpha.2023.12.007_bib62","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-022-00943-6","article-title":"Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome","volume":"117","author":"Selejan","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1540-8167.2007.01037.x","article-title":"AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat","volume":"19","author":"Kato","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jjcc.2011.06.003","article-title":"Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling","volume":"58","author":"Kato","year":"2011","journal-title":"J. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0039-3400541","article-title":"AGE-RAGE stress in the pathophysiology of atrial fibrillation and its treatment","volume":"29","author":"Prasad","year":"2020","journal-title":"Int. J. Angiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cvr\/cvu176","article-title":"Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats","volume":"104","author":"Saito","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib67","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2017.01.022","article-title":"Association between glycemic variability and major adverse cardiovascular and cerebrovascular events (MACCE) in patients with acute coronary syndrome during 30-day follow-up","volume":"466","author":"Xia","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpha.2023.12.007_bib68","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00059-022-05128-4","article-title":"Rhythm and metabolic control","volume":"47","author":"Guckel","year":"2022","journal-title":"Herz"},{"key":"10.1016\/j.jpha.2023.12.007_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.806013","article-title":"Correlation between blood glucose variability and early therapeutic effects after intravenous thrombolysis with alteplase and levels of serum inflammatory factors in patients with acute ischemic stroke","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jpha.2023.12.007_bib70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-020-0359-y","article-title":"Single-cell RNA sequencing in cardiovascular development, disease and medicine","volume":"17","author":"Paik","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib71","doi-asserted-by":"crossref","first-page":"747","DOI":"10.5551\/jat.RV17036","article-title":"Application of metabolomics to epidemiological studies of atherosclerosis and cardiovascular disease","volume":"26","author":"Iida","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.jpha.2023.12.007_bib72","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1515\/cclm-2021-0377","article-title":"Pre-analytical considerations in biomarker research: Focus on cardiovascular disease","volume":"59","author":"Revuelta-L\u00f3pez","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/db18-0317","article-title":"GLP-1 receptor in pancreatic \u03b1-cells regulates glucagon secretion in a glucose-dependent bidirectional manner","volume":"68","author":"Zhang","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jpha.2023.12.007_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.738848","article-title":"Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system","volume":"12","author":"Puglisi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jpha.2023.12.007_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-022-05396-5","article-title":"Glucagon-like peptide-1 attenuates diabetes-associated osteoporosis in ZDF rat, possibly through the RAGE pathway","volume":"23","author":"Cheng","year":"2022","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.jpha.2023.12.007_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1536\/ihj.19-327","article-title":"Exendin-4 reduces ventricular arrhythmia activity and calcium sparks-mediated sarcoplasmic reticulum Ca leak in rats with heart failure","volume":"61","author":"Chen","year":"2020","journal-title":"Int. Heart J."},{"key":"10.1016\/j.jpha.2023.12.007_bib77","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable risk factors and atrial fibrillation","volume":"136","author":"Lau","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jpha.2023.12.007_bib78","first-page":"210","article-title":"Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies, Diabetes Obes","volume":"21","author":"Bell","year":"2019","journal-title":"Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/1440-1681.13590","volume":"49","author":"Durak","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157917","article-title":"Favorable effects of GLP-1 receptor agonist against pancreatic \u03b2-cell glucose toxicity and the development of arteriosclerosis: \u201cthe earlier, the better\u201d in therapy with incretin-based medicine","volume":"22","author":"Kaneto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib81","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1159\/000341454","article-title":"Inhibition of the expression of TGF-\u03b21 and CTGF in human mesangial cells by exendin-4, a glucagon-like peptide-1 receptor agonist","volume":"30","author":"Li","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jpha.2023.12.007_bib82","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2015.12.007","article-title":"Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis","volume":"612","author":"Chen","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpha.2023.12.007_bib83","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022542","article-title":"Role of renal sympathetic nerves in GLP-1 (glucagon-like peptide-1) receptor agonist exendin-4-mediated diuresis and natriuresis in diet-induced obese rats","volume":"10","author":"Liu","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jpha.2023.12.007_bib84","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13105-022-00939-9","article-title":"Liraglutide provides cardioprotection through the recovery of mitochondrial dysfunction and oxidative stress in aging hearts","volume":"79","author":"Durak","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.jpha.2023.12.007_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114209","article-title":"A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction","volume":"182","author":"Qian","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpha.2023.12.007_bib86","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41371-019-0279-7","article-title":"Invited review: Hypertension and atrial fibrillation: Epidemiology, pathophysiology, and implications for management","volume":"33","author":"Gumprecht","year":"2019","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.jpha.2023.12.007_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175048","article-title":"Suppression of angiotensin II-activated NOX4\/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension","volume":"927","author":"Banks","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpha.2023.12.007_bib88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11154-014-9287-7","article-title":"Effects of GLP-1 in the kidney","volume":"15","author":"Skov","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.jpha.2023.12.007_bib89","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.120.14868","article-title":"Endogenous activation of glucagon-like peptide-1 receptor contributes to blood pressure control: Role of proximal tubule Na+\/H+ exchanger isoform 3, renal angiotensin II, and insulin sensitivity","volume":"76","author":"Martins","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jpha.2023.12.007_bib90","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm.3128","article-title":"GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure","volume":"19","author":"Kim","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49364-x","article-title":"Central glucagon-like peptide-1 receptor signaling via brainstem catecholamine neurons counteracts hypertension in spontaneously hypertensive rats","volume":"9","author":"Katsurada","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2023.12.007_bib92","doi-asserted-by":"crossref","first-page":"F1409","DOI":"10.1152\/ajprenal.00579.2019","article-title":"GLP-1-induced renal vasodilation in rodents depends exclusively on the known GLP-1 receptor and is lost in prehypertensive rats","volume":"318","author":"Jensen","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib93","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/STROKEAHA.121.037775","article-title":"Effects of semaglutide on stroke subtypes in type 2 diabetes: Post hoc analysis of the randomized SUSTAIN 6 and PIONEER 6","volume":"53","author":"Strain","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.jpha.2023.12.007_bib94","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/eurheartj\/ehv486","article-title":"The role of obesity in atrial fibrillation","volume":"37","author":"Nalliah","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jpha.2023.12.007_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes \u2013 state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib96","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/dc21-2656","article-title":"Efficacy and safety of once-weekly efpeglenatide monotherapy versus placebo in type 2 diabetes: The AMPLITUDE-M randomized controlled trial","volume":"45","author":"Frias","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpha.2023.12.007_bib97","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1111\/dom.14477","article-title":"Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes","volume":"23","author":"Quast","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molmet.2018.03.008","article-title":"Loss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity","volume":"11","author":"Lee","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib99","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41366-019-0513-y","article-title":"Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob\/ob mice","volume":"44","author":"Xu","year":"2020","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.jpha.2023.12.007_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109252","article-title":"GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1\u03b2-induced metabolic disturbance and mitochondrial dysfunction","volume":"332","author":"Zhang","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpha.2023.12.007_bib101","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.jacc.2021.03.314","article-title":"Fat-secreted ceramides regulate vascular redox state and influence outcomes in patients with cardiovascular disease","volume":"77","author":"Akawi","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccl.2019.01.002","article-title":"Pathophysiology of atrial fibrillation and heart failure: Dangerous interactions","volume":"37","author":"Sugumar","year":"2019","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.jpha.2023.12.007_bib103","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/07853890.2017.1306653","article-title":"Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: A meta-analysis of randomized controlled trials","volume":"49","author":"Huang","year":"2017","journal-title":"Ann. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64924-2","article-title":"Intermittent use of a short-course glucagon-like peptide-1 receptor agonist therapy limits adverse cardiac remodeling via Parkin-dependent mitochondrial turnover","volume":"10","author":"Germano","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2023.12.007_bib105","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-015-0476-7","article-title":"Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix","volume":"110","author":"Robinson","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib106","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-016-0272-9","article-title":"The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice","volume":"17","author":"Li","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jpha.2023.12.007_bib107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.peptides.2017.02.008","article-title":"Exendin-4 inhibits structural remodeling and improves Ca2+ homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS\/cGMP\/PKG pathway","volume":"90","author":"Chen","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.jpha.2023.12.007_bib108","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bbrc.2015.09.179","article-title":"Exendin-4 attenuates cardiac hypertrophy via AMPK\/mTOR signaling pathway activation","volume":"468","author":"Zhou","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2023.12.007_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00805","article-title":"Stimulation of GLP-1 receptor inhibits methylglyoxal-induced mitochondrial dysfunctions in H9c2 cardiomyoblasts: Potential role of epac\/PI3K\/Akt pathway","volume":"11","author":"Nuamnaichati","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2023.12.007_bib110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/FJC.0000000000000557","article-title":"Cardioprotective mechanisms of exenatide in isoprenaline-induced myocardial infarction: Novel effects on myocardial \u03b1-estrogen receptor expression and IGF-1\/IGF-2 system","volume":"71","author":"Darwesh","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jpha.2023.12.007_bib111","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.molmet.2017.08.010","article-title":"The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice","volume":"6","author":"Baggio","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib112","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE\u2212\/\u2212 and LDLr\u2212\/\u2212 mice by a mechanism that includes inflammatory pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.jpha.2023.12.007_bib113","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bph.12490","article-title":"Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration","volume":"171","author":"Wang","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2023.12.007_bib114","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"Arakawa","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jpha.2023.12.007_bib115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13300-020-00962-3","article-title":"Liraglutide reduces carotid intima-media thickness by reducing small dense low-density lipoproteins in a real-world setting of patients with type 2 diabetes: A novel anti-atherogenic effect","volume":"12","author":"Nikolic","year":"2021","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.jpha.2023.12.007_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97967-0","article-title":"Effect of liraglutide on expression of inflammatory genes in type 2 diabetes","volume":"11","author":"Zobel","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2023.12.007_bib117","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2019.09.021","article-title":"Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis","volume":"116","author":"Chang","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jpha.2023.12.007_bib118","first-page":"57","article-title":"Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis","volume":"14","author":"Hu","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib119","first-page":"127","article-title":"Atrial fibrillation in obstructive sleep apnea: Neural mechanisms and emerging therapies, Trends Cardiovasc","volume":"31","author":"Huang","year":"2021","journal-title":"Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib120","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCRESAHA.121.319874","article-title":"GLP1R attenuates sympathetic response to high glucose via carotid body inhibition","volume":"130","author":"Pauza","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib121","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mce.2018.11.015","article-title":"Recombinant human glucagon-like peptide-1 protects against chronic intermittent hypoxia by improving myocardial energy metabolism and mitochondrial biogenesis","volume":"481","author":"Tao","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jpha.2023.12.007_bib122","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","article-title":"Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy","volume":"110","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jpha.2023.12.007_bib123","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.106.100982","article-title":"Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts","volume":"317","author":"Zhao","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpha.2023.12.007_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101641","article-title":"Glucagon-like peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction","volume":"66","author":"McLean","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib125","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00380-018-01327-4","article-title":"Liraglutide suppresses atrial electrophysiological changes","volume":"34","author":"Nakamura","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jpha.2023.12.007_bib126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12012-020-09567-5","article-title":"Exendin-4 ameliorates cardiac remodeling in experimentally induced myocardial infarction in rats by inhibiting PARP1\/NF-\u03baB axis in A SIRT1-dependent mechanism","volume":"20","author":"Eid","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.jpha.2023.12.007_bib127","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10557-020-07006-9","article-title":"Exendin-4 attenuates remodeling in the remote myocardium of rats after an acute myocardial infarction by activating \u03b2-arrestin-2, protein phosphatase 2A, and glycogen synthase kinase-3 and inhibiting \u03b2-catenin","volume":"35","author":"Eid","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.jpha.2023.12.007_bib128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1074248420942007","article-title":"Liraglutide attenuates myocardial fibrosis via inhibition of AT1R-mediated ROS production in hypertensive mice","volume":"26","author":"Chen","year":"2021","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.jpha.2023.12.007_bib129","doi-asserted-by":"crossref","first-page":"H295","DOI":"10.1152\/ajpheart.00990.2012","article-title":"Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes","volume":"305","author":"Monji","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173318","article-title":"Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR\/p70S6K signaling and promoting autophagy","volume":"883","author":"Zheng","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpha.2023.12.007_bib131","doi-asserted-by":"crossref","first-page":"E630","DOI":"10.1152\/ajpendo.00109.2014","article-title":"Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium","volume":"307","author":"DeNicola","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib132","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yjmcc.2014.08.022","article-title":"Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes","volume":"76","author":"Younce","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib133","doi-asserted-by":"crossref","first-page":"C270","DOI":"10.1152\/ajpcell.00194.2015","article-title":"Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts","volume":"310","author":"Du","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jpha.2023.12.007_bib134","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S213910","article-title":"Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats","volume":"13","author":"Zheng","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jpha.2023.12.007_bib135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-020-01000-z","article-title":"Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet","volume":"19","author":"Sukumaran","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.jpha.2023.12.007_bib136","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/cvr\/cvaa256","article-title":"The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction","volume":"117","author":"Withaar","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jpha.2023.12.007_bib137","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10561-022-10021-9","article-title":"Liraglutide inhibits AngII-induced cardiac fibroblast proliferation and ECM deposition through regulating miR-21\/PTEN\/PI3K pathway","volume":"24","author":"Wang","year":"2023","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.jpha.2023.12.007_bib138","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib139","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib140","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2023.12.007_bib141","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2023.12.007_bib142","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.numecd.2020.03.013","article-title":"Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials","volume":"30","author":"Nreu","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.jpha.2023.12.007_bib143","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/dom.14634","article-title":"Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial","volume":"24","author":"Raubenheimer","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib144","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/dom.14862","article-title":"Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial","volume":"25","author":"Neves","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2023.12.007_bib146","article-title":"SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: A clinical practice guideline","volume":"373","author":"Li","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jpha.2023.12.007_bib147","doi-asserted-by":"crossref","DOI":"10.1097\/XCE.0000000000000265","article-title":"Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?","volume":"11","author":"Thotamgari","year":"2022","journal-title":"Cardiovasc. Endocrinol. Metab."},{"key":"10.1016\/j.jpha.2023.12.007_bib148","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2213-8587(19)30422-X","article-title":"Association of glucose-lowering medications with cardiovascular outcomes: An umbrella review and evidence map","volume":"8","author":"Zhu","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jpha.2023.12.007_bib149","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ejhf.657","article-title":"Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial","volume":"19","author":"Jorsal","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jpha.2023.12.007_bib150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2337\/dc16-1580","article-title":"Effects of liraglutide on heart rate and heart rate variability: A randomized, double-blind, placebo-controlled crossover study","volume":"40","author":"Kumarathurai","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpha.2023.12.007_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4223","article-title":"Exacerbation of atrial fibrillation related to dulaglutide use","volume":"9","author":"Lee","year":"2021","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.jpha.2023.12.007_bib152","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01106-4","article-title":"Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: Combined post hoc analysis of the SUSTAIN and PIONEER trials","volume":"19","author":"Husain","year":"2020","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177923002903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177923002903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:51:03Z","timestamp":1730829063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177923002903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":152,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2095177923002903"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2023.12.007","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2023.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"100917"}}